[Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
Arnold
R
R
Abteilung Gastroenterologie und Stoffwechsel, Universität Marburg.
Neuhaus
C
C
Trautmann
M E
ME
D015408:Gastrinoma / Q000188:drug therapy*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D005935:Glucagonoma / Q000188:drug therapy*; D006801:Humans; D007340:Insulinoma / Q000188:drug therapy*; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D009377:Multiple Endocrine Neoplasia / Q000188:drug therapy*; D009362:Neoplasm Metastasis; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D013997:Time Factors; D003969:Vipoma / Q000188:drug therapy*
D015282:Octreotide
Therapie endokriner gastroenteropankreatischer Tumoren mit dem Somatostatin-Analogon Octreotid.